exRNAdisease

Entry Detail

---



General Information

Database ID: exR0269458 RNA Name: hsa-miR-18a-5p RNA Type: miRNA Chromosome: chr13 Starnd: + Coordinate: Start Site(bp): 91350756 End Site(bp): 91350778 External Links: hsa-miR-18a-5p

Disease Information

Disease Name: Multiple Sclerosis Disease Category: Nervous System Diseases MeSH ID: D009103 Type: Diseases Category/Nervous System Diseases Alias: Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating

Expression Detail

GEO ID: GSE140106 Description: Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment Experimental Design: Fingolimod treatment Case Disease Type: Multiple Sclerosis Case Disease SubType: NA Case Sample: Fingolimod treated Multiple Sclerosis Control Sample: Untreated Number of Case: 27 Number of Control: 27 Number of Samples: 54

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand PATZ1 chr22 31325804 31346346 - TUBA4A chr2 219249710 219278170 - SURF4 chr9 133361450 133376166 - DDX5 chr17 64498254 64508199 - SND1 chr7 127652194 128092609 + HIF1AN chr10 100529072 100559998 + SIK2 chr11 111602449 111730855 + FKBP1A chr20 1368978 1393172 - USP10 chr16 84699978 84779922 + PARL chr3 183829271 183884933 - ASF1B chr19 14119512 14136613 - PRPF38B chr1 108692310 108702928 + ADAT2 chr6 143422832 143450695 - ZNF12 chr7 6688433 6706947 - DNAJC9 chr10 73183362 73247255 - AC131160.1 chr3 183815568 183884889 - ACSS2 chr20 34872146 34927962 + MRPS18A chr6 43671303 43687791 - XRCC6 chr22 41621119 41664048 + ROMO1 chr20 35699272 35700984 + PEX5 chr12 7188685 7218574 + NDUFV2 chr18 9102630 9134345 + UBE2Z chr17 48908407 48929056 + NOP58 chr2 202265736 202303661 + RNF4 chr4 2462220 2625320 + CHD1 chr5 98853985 98928957 - ATP2B1 chr12 89588049 89709300 - SLC41A1 chr1 205789094 205813748 - NCDN chr1 35557473 35567274 + HMGCS1 chr5 43287470 43313512 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000712 chr16 68208276 68225678 + hsa_circ_0001186 chr21 35475133 35475818 + hsa_circ_0001247 chr22 46125304 46136418 + hsa_circ_0000921 chr19 30476129 30477324 + hsa_circ_0000943 chr19 47421744 47440665 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC073896.4 chr12 56162359 56190284 - AC093010.3 chr3 114314501 114329714 - AC145207.5 chr17 81878425 81881106 - AL162171.3 chr14 88589231 88592408 + AP005263.1 chr18 9102736 9254346 + CASC2 chr10 118046279 118210158 + GAS5 chr1 173858559 173868882 - NEAT1 chr11 65422774 65445540 + SNHG1 chr11 62851984 62855953 - SNHG15 chr7 44983023 44986961 - XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE140106 Sample Source: Blood Source Fraction: Exosome Platform: GPL11154 Method: NGS Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1907 Sample treatment protocol: Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). RNA Extract protocol: Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol. RNA library preparation protocol: Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.

Reference

PMID: 31721043 Title: Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment Author: Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F Journal: Mol Neurobiol. 2020 Feb;57(2):1245-1258. Description: we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.